BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8635013)

  • 1. The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of "borderline" ovarian tumors.
    Lawrence WD
    Cancer; 1995 Nov; 76(10 Suppl):2138-42. PubMed ID: 8635013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
    Prat J
    Adv Anat Pathol; 1999 Sep; 6(5):247-74. PubMed ID: 10472378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data.
    Gilks CB
    Int J Gynecol Pathol; 2004 Jul; 23(3):200-5. PubMed ID: 15213595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
    Hauptmann S; Friedrich K; Redline R; Avril S
    Virchows Arch; 2017 Feb; 470(2):125-142. PubMed ID: 28025670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J; McCluggage WG
    Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.
    Giurgea LN; Ungureanu C; Mihailovici MS
    Rom J Morphol Embryol; 2012; 53(4):967-73. PubMed ID: 23303020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serous and mucinous epithelial ovarian tumors--a clinicopathologic study of 116 cases].
    Giurgea NL; Pitrop M; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):389-94. PubMed ID: 23077925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Organization classification and nomenclature of ovarian cancer.
    Scully RE
    Natl Cancer Inst Monogr; 1975 Oct; 42():5-7. PubMed ID: 1234636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial ovarian tumors of borderline malignancy.
    Chao TM; Yen MS; Chao KC; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocalyxin-like protein 1 expression and correlation with clinical characteristics in epithelial serous and mucinous ovarian carcinoma and tumor-like lesions.
    Ye F; Hu Y; Zhou C; Hu Y; Chen H
    Pathobiology; 2012; 79(6):307-13. PubMed ID: 22688257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine needle aspiration of borderline ovarian lesions. Is It useful?
    Athanassiadou P; Grapsa D
    Acta Cytol; 2005; 49(3):278-85. PubMed ID: 15966290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
    Ronnett BM; Kajdacsy-Balla A; Gilks CB; Merino MJ; Silva E; Werness BA; Young RH
    Hum Pathol; 2004 Aug; 35(8):949-60. PubMed ID: 15297962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
    Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
    Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear findings of ovarian surface epithelial tumors.
    Hirokawa M; Miyake Y; Shimizu M; Kanahara T; Manabe T; Fujiwara K; Kohno I
    Diagn Cytopathol; 2000 Jan; 22(1):27-9. PubMed ID: 10613969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.